Literature DB >> 33093026

Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.

Larry K Kociolek1,2, William J Muller1,2, Rebecca Yee3, Jennifer Dien Bard3,4, Cameron A Brown5,6, Paula A Revell5,6, Hanna Wardell7, Timothy J Savage7, Sarah Jung8, Samuel Dominguez8,9, Bijal A Parikh10, Robert C Jerris11,12, Sue C Kehl13,14, Aaron Campigotto15, Jeffrey M Bender16,4, Xiaotian Zheng17,2, Emily Muscat1,17, Matthew Linam12,18, Lisa Abuogi9, Christiana Smith9, Kelly Graff9, Ariel Hernandez-Leyva19, David Williams20, Nira R Pollock21.   

Abstract

The distribution of upper respiratory viral loads (VL) in asymptomatic children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unknown. We assessed PCR cycle threshold (Ct) values and estimated VL in infected asymptomatic children diagnosed in nine pediatric hospital testing programs. Records for asymptomatic and symptomatic patients with positive clinical SARS-CoV-2 tests were reviewed. Ct values were (i) adjusted by centering each value around the institutional median Ct value from symptomatic children tested with that assay and (ii) converted to estimated VL (numbers of copies per milliliter) using internal or manufacturer data. Adjusted Ct values and estimated VL for asymptomatic versus symptomatic children (118 asymptomatic versus 197 symptomatic children aged 0 to 4 years, 79 asymptomatic versus 97 symptomatic children aged 5 to 9 years, 69 asymptomatic versus 75 symptomatic children aged 10 to 13 years, 73 asymptomatic versus 109 symptomatic children aged 14 to 17 years) were compared. The median adjusted Ct value for asymptomatic children was 10.3 cycles higher than for symptomatic children (P < 0.0001), and VL were 3 to 4 logs lower than for symptomatic children (P < 0.0001); differences were consistent (P < 0.0001) across all four age brackets. These differences were consistent across all institutions and by sex, ethnicity, and race. Asymptomatic children with diabetes (odds ratio [OR], 6.5; P = 0.01), a recent contact (OR, 2.3; P = 0.02), and testing for surveillance (OR, 2.7; P = 0.005) had higher estimated risks of having a Ct value in the lowest quartile than children without, while an immunocompromised status had no effect. Children with asymptomatic SARS-CoV-2 infection had lower levels of virus in their nasopharynx/oropharynx than symptomatic children, but the timing of infection relative to diagnosis likely impacted levels in asymptomatic children. Caution is recommended when choosing diagnostic tests for screening of asymptomatic children.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; diagnostics; pediatric infectious disease

Year:  2020        PMID: 33093026     DOI: 10.1128/JCM.02593-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Low frequency of SARS-CoV2 infection in daycare centers during the reopening of school activities in the Southeast's poor area of Brazil.

Authors:  Graciela Dos Santos Soares; Lucas Vinicius Morais; Kevin Cézar Nascimento Silva; Elaine Moura Ferreira; Marina Tiemi Shio; Camila Malta Romano; Carla Regiani Conde; Ester Cerdeira Sabino; Carolina Nunes França; Luiz Henrique Nali
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-06-24       Impact factor: 2.169

2.  COVID-19 in Children: Correlation Between Epidemiologic, Clinical Characteristics, and RT-qPCR Cycle Threshold Values.

Authors:  Angela Gentile; María Del Valle Juarez; María Florencia Lucion; María Natalia Pejito; Sofia Alexay; Ana Sofia Orqueda; Lucia Romero Bollon; Alicia Mistchenko
Journal:  Pediatr Infect Dis J       Date:  2022-07-13       Impact factor: 3.806

3.  Saliva Is a Promising Alternative Specimen for the Detection of SARS-CoV-2 in Children and Adults.

Authors:  Rebecca Yee; Thao T Truong; Pia S Pannaraj; Natalie Eubanks; Emily Gai; Jaycee Jumarang; Lauren Turner; Ariana Peralta; Yesun Lee; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

4.  A rapid near-patient detection system for SARS-CoV-2 using saliva.

Authors:  Noah B Toppings; Abu Naser Mohon; Yoonjung Lee; Hitendra Kumar; Daniel Lee; Ratik Kapoor; Gurmukh Singh; Lisa Oberding; Omar Abdullah; Keekyoung Kim; Byron M Berenger; Dylan R Pillai
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.379

5.  The diagnostic accuracy of RT-PCR from self-collected saliva versus nasopharyngeal sampling: A systematic review and meta-analysis.

Authors:  Do Hyun Kim; Mohammed A Basurrah; Jae Hong Han; Sung Won Kim; Se Hwan Hwang
Journal:  Saudi Med J       Date:  2022-01       Impact factor: 1.422

6.  Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection.

Authors:  Alvin Kuo Jing Teo; Yukti Choudhury; Iain Beehuat Tan; Chae Yin Cher; Shi Hao Chew; Zi Yi Wan; Lionel Tim Ee Cheng; Lynette Lin Ean Oon; Min Han Tan; Kian Sing Chan; Li Yang Hsu
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

7.  Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Children in a Large Regional US Health System During the Coronavirus Disease 2019 Pandemic.

Authors:  David R Peaper; Christina Murdzek; Carlos R Oliveira; Thomas S Murray
Journal:  Pediatr Infect Dis J       Date:  2021-03-01       Impact factor: 2.129

8.  Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.

Authors:  Erin Chung; Eric J Chow; Naomi C Wilcox; Roy Burstein; Elisabeth Brandstetter; Peter D Han; Kairsten Fay; Brian Pfau; Amanda Adler; Kirsten Lacombe; Christina M Lockwood; Timothy M Uyeki; Jay Shendure; Jeffrey S Duchin; Mark J Rieder; Deborah A Nickerson; Michael Boeckh; Michael Famulare; James P Hughes; Lea M Starita; Trevor Bedford; Janet A Englund; Helen Y Chu
Journal:  JAMA Pediatr       Date:  2021-10-04       Impact factor: 26.796

9.  High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients With COVID-19.

Authors:  Utsav Pandey; Rebecca Yee; Lishuang Shen; Alexander R Judkins; Moiz Bootwalla; Alex Ryutov; Dennis T Maglinte; Dejerianne Ostrow; Mimi Precit; Jaclyn A Biegel; Jeffrey M Bender; Xiaowu Gai; Jennifer Dien Bard
Journal:  Open Forum Infect Dis       Date:  2020-11-13       Impact factor: 3.835

10.  Considerations for Assessment and Deployment of Rapid Antigen Tests for Diagnosis of Coronavirus Disease 2019.

Authors:  Nira R Pollock; Francesca Lee; Christine C Ginocchio; Joseph D Yao; Romney M Humphries
Journal:  Open Forum Infect Dis       Date:  2021-03-07       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.